NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.57
+0.12 (0.65%)
At close: Jun 27, 2025, 4:00 PM
19.30
+0.73 (3.93%)
After-hours: Jun 27, 2025, 4:31 PM EDT
NAMS Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for NAMS stock ranges from a low of $37 to a high of $52. The average analyst price target of $42.88 forecasts a 130.91% increase in the stock price over the next year.
Price Target: $42.88 (+130.91%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NAMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +126.17% | Jun 17, 2025 |
| Needham | Needham | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +115.40% | Jun 12, 2025 |
| Stifel | Stifel | Strong Buy Initiates $44 | Strong Buy | Initiates | $44 | +136.94% | Jun 10, 2025 |
| Needham | Needham | Strong Buy Maintains $42 → $40 | Strong Buy | Maintains | $42 → $40 | +115.40% | May 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +126.17% | Apr 8, 2025 |
Financial Forecast
Revenue This Year
18.52M
from 45.56M
Decreased by -59.36%
Revenue Next Year
15.33M
from 18.52M
Decreased by -17.21%
EPS This Year
-1.84
from -2.56
EPS Next Year
-2.10
from -1.84
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 29.4M | 61.2M | 264.0M | ||
| Avg | 18.5M | 15.3M | 125.5M | ||
| Low | 2.9M | n/a | 34.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -35.5% | 230.3% | 1,622.4% | ||
| Avg | -59.4% | -17.2% | 718.7% | ||
| Low | -93.6% | - | 123.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.54 | -1.68 | -0.30 | ||
| Avg | -1.84 | -2.10 | -1.58 | ||
| Low | -2.22 | -2.91 | -2.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.